Mullerian hormone (AMH) antibody and antigen (Recombinant protein)

Diagnostic Mullerian hormone (AMH) antibodies (anti-Mullerian hormone, anti-AMH) and antigens (recombinant Mullerian hormone (AMH) protein) for Fertility AMH detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-AMH-Ag01 Recombinant human AMH/MIF Protein 3090
GMP-h-AMH-Ab01 Anti-human AMH/MIF mouse monoclonal antibody (mAb) 1953
GMP-h-AMH-Ab02 Anti-human AMH/MIF mouse monoclonal antibody (mAb) 1953
GMP-h-AMH-Ab03 Anti-human AMH/MIF human monoclonal antibody (mAb) 1953
GMP-h-AMH-Ab04 Anti-human AMH/MIF human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-h-AMH-Ag01
Product Name Recombinant human AMH/MIF Protein
Target/Biomarker Mullerian hormone (AMH)
Alias of Target/Biomarker MIF, MIS
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation Mullerian hormone (AMH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AMH level test of Fertility (polycystic ovary syndrome (PCOS)) and related syndrome evaluation.
Tag His
Products description Recombinant human AMH/MIF Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-AMH-Ab01, GMP-h-AMH-Ab02
Product Name Anti-human AMH/MIF mouse monoclonal antibody (mAb)
Target/Biomarker Mullerian hormone (AMH)
Alias of Target/Biomarker MIF, MIS
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Mullerian hormone (AMH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AMH level test of Fertility (polycystic ovary syndrome (PCOS)) and related syndrome evaluation.
Tag mFc
Products description Anti-human AMH/MIF mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-AMH-Ab03, GMP-h-AMH-Ab04
Product Name Anti-human AMH/MIF human monoclonal antibody (mAb)
Target/Biomarker Mullerian hormone (AMH)
Alias of Target/Biomarker MIF, MIS
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Mullerian hormone (AMH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AMH level test of Fertility (polycystic ovary syndrome (PCOS)) and related syndrome evaluation.
Tag hFc
Products description Anti-human AMH/MIF human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    What is an anti-müllerian hormone (AMH) test? This test measures the level of anti-müllerian hormone (AMH) in the blood. AMH is made in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on your age and gender. AMH plays an important role in the development of sex organs in an unborn baby. During the first weeks of pregnancy, a baby will start developing reproductive organs. The baby will already have the genes to become either a male (XY genes) or a female (XX genes). If the baby has male (XY) genes, high levels of AMH are made, along with other male hormones. This prevents the development of female organs and promotes the formation of male organs. If there is not enough AMH to stop the development of female organs, organs of both sexes may form. When this happens, a baby's genitals may not be clearly identified as male or female. This is known as ambiguous genitalia. Another name for this condition is intersex. If the unborn baby has female (XX) genes small amounts of AMH are made. This allows for the development of female reproductive organs. AMH has a different role for females after puberty. At that time, the ovaries (glands that make egg cells) begin making AMH. The more egg cells there are, the higher the level of AMH. In women, AMH levels can provide information about fertility, the ability to get pregnant. The test may also be used to help diagnose menstrual disorders or to monitor the health of women with certain types of ovarian cancer. Other names: AMH hormone test, müllerian-inhibiting hormone, MIH, müllerian inhibiting factor, MIF, müllerian-inhibiting substance, MIS What is it used for? An AMH test is often used to check a woman's ability to produce eggs that can be fertilized for pregnancy. A woman's ovaries can make thousands of eggs during her childbearing years. The number declines as a woman gets older. AMH levels help show how many potential egg cells a woman has left. This is known as the ovarian reserve. If a woman's ovarian reserve is high, she may have a better chance of getting pregnant. She may also be able to wait months or years before trying to get pregnant. If the ovarian reserve is low, it may mean a woman will have trouble getting pregnant, and should not delay very long before trying to have a baby. AMH tests may also be used to: Predict the start of menopause, a time in a woman's life when her menstrual periods have stopped and she can't become pregnant anymore. It usually starts when a woman is around 50 years old. Find out the reason for early menopause Help find out the reason for amenorrhea, the lack of menstruation. It is most often diagnosed in girls who haven't started menstruating by the age of 15 and in women who have missed several periods. Help diagnose polycystic ovary syndrome (PCOS), a hormonal disorder that is a common cause of female infertility, the inability to get pregnant Check infants with genitals that are not clearly identified as male or female Monitor women who have certain types of ovarian cancer https://medlineplus.gov/lab-tests/anti-mullerian-hormone-test/



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    Barbara Martin 2024-03-20 21:47:36
    AMH antibody also provides high stability and does not affect the quality of data that is suitable for ELISA tests. That makes its performance precise in diagnosing the health conditions of patients.

    Leave a comment